[Metabolic syndrome and rheumatic diseases]
Terapevticheskii Arkhiv
|August 3, 2006
Summary
Metabolic syndrome (MS) significantly increases the risk of rheumatic diseases (RD), particularly osteoarthrosis and gout. Early detection and management of MS are crucial for preventing associated joint conditions.
Area of Science:
- Rheumatology
- Endocrinology
- Internal Medicine
Background:
- Metabolic syndrome (MS) is a cluster of conditions that increase the risk of heart disease, stroke, and diabetes.
- Rheumatic diseases (RD) encompass a wide range of conditions affecting joints, muscles, and bones.
- The interplay between MS and RD requires further characterization to understand prevalence and clinical features.
Purpose of the Study:
- To determine the prevalence of rheumatic diseases in patients diagnosed with metabolic syndrome.
- To identify the most common types of rheumatic diseases and their characteristics in patients with MS.
- To investigate the prevalence and features of metabolic disturbances in patients with established rheumatic diseases.
Main Methods:
- A cross-sectional study involving 1291 adult patients screened for metabolic syndrome (MS).
- Patients with MS were further evaluated for the presence of rheumatic diseases (RD).
- Concurrently, 1212 RD patients were assessed for various components of MS, including hypertension, obesity, and dyslipidemia.
Main Results:
- Metabolic syndrome was identified in 24.6% of the study population.
- Rheumatic diseases were present in 93.1% of patients with MS, with osteoarthrosis, osteochondrosis, and osteoporosis being most frequent.
- Metabolic disturbances were universally observed in RD patients, with the highest prevalence noted in those with gout and osteoarthrosis.
Conclusions:
- Patients with metabolic syndrome represent a high-risk group for developing rheumatic diseases.
- Gout and osteoarthrosis are particularly common rheumatic conditions observed in individuals with metabolic syndrome.
- Understanding these associations is vital for comprehensive patient care and risk stratification.
More Related Videos
09:18Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
Published on: February 24, 2023
06:04Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
Published on: September 27, 2024
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...